Chemotherapy Stocks List

Recent Signals

Date Stock Signal Type
2020-08-06 ALKS 50 DMA Support Bullish
2020-08-06 ALKS MACD Bearish Centerline Cross Bearish
2020-08-06 ATNX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-06 BNTC Bollinger Band Squeeze Range Contraction
2020-08-06 BNTC NR7 Range Contraction
2020-08-06 BNTC Crossed Above 200 DMA Bullish
2020-08-06 BNTC Pocket Pivot Bullish Swing Setup
2020-08-06 BNTC Narrow Range Bar Range Contraction
2020-08-06 BYSI Evening Star Bearish
2020-08-06 BYSI Narrow Range Bar Range Contraction
2020-08-06 CBLI Fell Below 20 DMA Bearish
2020-08-06 CCM Upper Bollinger Band Walk Strength
2020-08-06 CCM Calm After Storm Range Contraction
2020-08-06 CHRS Bollinger Band Squeeze Range Contraction
2020-08-06 CHRS 20 DMA Resistance Bearish
2020-08-06 CHRS Fell Below 50 DMA Bearish
2020-08-06 CHRS Fell Below 200 DMA Bearish
2020-08-06 CKPT MACD Bearish Signal Line Cross Bearish
2020-08-06 CKPT Fell Below 20 DMA Bearish
2020-08-06 CLRB Narrow Range Bar Range Contraction
2020-08-06 CLRB NR7-2 Range Contraction
2020-08-06 CLRB Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-08-06 CLRB Bollinger Band Squeeze Range Contraction
2020-08-06 CLRB NR7 Range Contraction
2020-08-06 CLRB Calm After Storm Range Contraction
2020-08-06 CLSN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-06 CLSN Narrow Range Bar Range Contraction
2020-08-06 CLSN NR7 Range Contraction
2020-08-06 CRDF Upper Bollinger Band Walk Strength
2020-08-06 CRDF Slingshot Bullish Bullish Swing Setup
2020-08-06 DCTH New 52 Week Closing High Bullish
2020-08-06 DFFN Fell Below 20 DMA Bearish
2020-08-06 GLYC NR7 Range Contraction
2020-08-06 GLYC Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-08-06 HRTX 180 Bearish Setup Bearish Swing Setup
2020-08-06 HRTX MACD Bearish Signal Line Cross Bearish
2020-08-06 HRTX Fell Below 20 DMA Bearish
2020-08-06 ICUI Stochastic Reached Oversold Weakness
2020-08-06 INFU 20 DMA Support Bullish
2020-08-06 KZIA Pocket Pivot Bullish Swing Setup
2020-08-06 KZIA 20 DMA Support Bullish
2020-08-06 MACK 20 DMA Support Bullish
2020-08-06 MACK Fell Below 200 DMA Bearish
2020-08-06 MACK Fell Below 50 DMA Bearish
2020-08-06 MBRX Narrow Range Bar Range Contraction
2020-08-06 MBRX 20 DMA Support Bullish
2020-08-06 MRSN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-06 MRSN NR7 Range Contraction
2020-08-06 MRSN Narrow Range Bar Range Contraction
2020-08-06 ORIC Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-06 ORIC Pocket Pivot Bullish Swing Setup
2020-08-06 ORIC Crossed Above 20 DMA Bullish
2020-08-06 SGEN Stochastic Reached Oversold Weakness
2020-08-06 SGEN Lower Bollinger Band Walk Weakness
2020-08-06 SPPI MACD Bullish Signal Line Cross Bullish
2020-08-06 URGN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-08-06 VERU 20 DMA Support Bullish
2020-08-06 VNDA Expansion Pivot Buy Setup Bullish Swing Setup
2020-08-06 VNDA Crossed Above 50 DMA Bullish
2020-08-06 ZEAL 180 Bearish Setup Bearish Swing Setup
2020-08-06 ZEAL Narrow Range Bar Range Contraction
2020-08-06 ZEAL Fell Below 20 DMA Bearish
2020-08-06 ZEAL NR7 Range Contraction
2020-08-06 ZEAL Bollinger Band Squeeze Range Contraction

Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent (which almost always involves combinations of drugs), or it may aim to prolong life or to reduce symptoms (palliative chemotherapy). Chemotherapy is one of the major categories of the medical discipline specifically devoted to pharmacotherapy for cancer, which is called medical oncology.
The term chemotherapy has come to connote non-specific usage of intracellular poisons to inhibit mitosis, cell division. The connotation excludes more selective agents that block extracellular signals (signal transduction). The development of therapies with specific molecular or genetic targets, which inhibit growth-promoting signals from classic endocrine hormones (primarily estrogens for breast cancer and androgens for prostate cancer) are now called hormonal therapies. By contrast, other inhibitions of growth-signals like those associated with receptor tyrosine kinases are referred to as targeted therapy.
Importantly, the use of drugs (whether chemotherapy, hormonal therapy or targeted therapy) constitutes systemic therapy for cancer in that they are introduced into the blood stream and are therefore in principle able to address cancer at any anatomic location in the body. Systemic therapy is often used in conjunction with other modalities that constitute local therapy (i.e. treatments whose efficacy is confined to the anatomic area where they are applied) for cancer such as radiation therapy, surgery or hyperthermia therapy.
Traditional chemotherapeutic agents are cytotoxic by means of interfering with cell division (mitosis) but cancer cells vary widely in their susceptibility to these agents. To a large extent, chemotherapy can be thought of as a way to damage or stress cells, which may then lead to cell death if apoptosis is initiated. Many of the side effects of chemotherapy can be traced to damage to normal cells that divide rapidly and are thus sensitive to anti-mitotic drugs: cells in the bone marrow, digestive tract and hair follicles. This results in the most common side-effects of chemotherapy: myelosuppression (decreased production of blood cells, hence also immunosuppression), mucositis (inflammation of the lining of the digestive tract), and alopecia (hair loss). Because of the effect on immune cells (especially lymphocytes), chemotherapy drugs often find use in a host of diseases that result from harmful overactivity of the immune system against self (so-called autoimmunity). These include rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, vasculitis and many others.

More about Chemotherapy